Clinical Trials Directory

Trials / Terminated

TerminatedNCT03862027

Safety of Optimal PEEP in NSICU Patients

Evaluating Safety of Transpulmonary Pressure Guided PEEP Management in Neurocritical Care Patients

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
1 (actual)
Sponsor
University of North Carolina, Chapel Hill · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The investigators aim to demonstrate that use of transpulmonary pressure to guide PEEP management is safe in patients with possible elevations of intracranial pressure.

Detailed description

Purpose: To establish safety of titrating PEEP based on transpulmonary pressure as measured by an esophageal balloon in mechanically ventilated neurosurgical patients. Participants: Adult patients admitted to the Neuro ICU at UNC Hospital and requiring mechanical ventilation who have an intracranial pressure monitoring device in place. Procedures (methods): All enrolled patients will have esophageal balloons placed with measurement of transpulmonary pressures. All patients will have baseline measurements recorded of intracranial pressure, cerebral perfusion pressure, and cerebral autoregulation. PEEP will then be titrated based on transpulmonary pressure measurements with recording of physiological measurements over the next hour. At the conclusion of the hour, all patients will be returned to their prior ventilator settings.

Conditions

Interventions

TypeNameDescription
DEVICEEsophageal Balloon catheterPressures \[Esophageal Pressure (Pes), Airway Pressure (Paw), and Transpulmonary Pressure (Ptp)\] are measured directly through the ventilator. The waveforms of Paw, Pes, and Ptp will be visualized on the ventilator. Ptp is obtained from Paw - Pes. All patients will have baseline measurements recorded of ICP, CPP, and MAP. PEEP will be increased on the ventilator to achieve a Ptp between 0 and +2 cm H2O ("Optimal PEEP"). Measurements of Intracranial pressure (ICP), cerebral perfusion pressure (CPP), and mean arterial pressure (MAP) will be repeated 5 minutes after the change in PEEP.

Timeline

Start date
2019-03-01
Primary completion
2019-03-04
Completion
2019-03-04
First posted
2019-03-05
Last updated
2021-04-27
Results posted
2021-04-01

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03862027. Inclusion in this directory is not an endorsement.